VCM
IRMD icon

Versant Capital Management’s iRadimed IRMD Stock Holding History

Versant Capital Management’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.94K Hold
104
– – ﹤0.01% 2235
2026
Q1 		$10K Hold
104
– – ﹤0.01% 2143
2025
Q4 		$10.1K Hold
104
– – ﹤0.01% 1987
2025
Q3 		$7.4K Hold
104
– – ﹤0.01% 2058
2025
Q2 		$6.22K Hold
104
– – ﹤0.01% 2083
2025
Q1 		$5.46K Hold
104
– – ﹤0.01% 1999
2024
Q4 		$5.72K Buy
+104
New +$5.47K ﹤0.01% 1697

Other funds holding IRMD

SI
Shaker Investments Cleveland, Ohio $278M AUM 69.83% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
EA
Ellsworth Advisors Hudson, Ohio $609M AUM 52.37% 1-Year Est. Return
KPP
Kings Path Partners Sugar Land, Texas $376M AUM 19% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
BP
Ballentine Partners Waltham, Massachusetts $8.18B AUM 27.59% 1-Year Est. Return
SWM
Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return
1IA
1620 Investment Advisors Plymouth, Massachusetts $161M AUM 30.15% 1-Year Est. Return

Versant Capital Management's IRMD Position: Q2 2026 in Review

Versant Capital Management held its iRadimed (IRMD) position steady in Q2 2026 at 104 shares worth $9.94K. The position accounts for ﹤0.01% of the portfolio, ranked #2235.

Versant Capital Management first reported a position in IRMD in Q4 2024 and has held it in 7 quarters since. The position peaked at $10.1K in Q4 2025. 18 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

  • Versant Capital Management held 104 shares of iRadimed worth $9.94K as of Q2 2026.
  • Versant Capital Management left its iRadimed share count unchanged in Q2 2026.
  • iRadimed made up ﹤0.01% of Versant Capital Management's portfolio in Q2 2026, its #2235 holding.
  • Versant Capital Management first reported a position in iRadimed in Q4 2024 and has held it in 7 quarters since.
  • Versant Capital Management's iRadimed position peaked at $10.1K in Q4 2025.
  • 18 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.